NSRX
Nasus Pharma·AMEX
--
--(--)
--
--(--)
NSRX Filings
Filing Date
Form Description
Form Type
2026-01-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-10
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-10 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
